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ABSTRACT 
An experiment was conducted using forty-one Bonsmara steers (age ± 7 months) to 
determine the effect of zilpaterol hydrochloride (ZH) on the growth performance and 
carcass characteristics. The trial was structured using a completely randomized design 
with two treatments, control and ZH group. The steers were fed ZH for 28 consecutive 
days at the end of the finishing period and ZH was withdrawn from the diet 2 days prior to 
slaughter of the animals. The steers were placed in individual pens and weighed 
fortnightly throughout the 4 months trial. Zilpaterol hydrochloride (ZH) was included in the 
diet at a rate of 8.3 mg/kg of DM. Feeding of ZH increased (P< 0.05) body weight (BW) 
gain and ADG (1.102 vs. 1.444) and tended to increase (P = 0.067) feed efficiency (F:G) 
during the last month of the finishing period. There were no significant differences (P> 
0.05) in daily dry matter intakes (DMI). For the control group, high treatment weight gains 
were significantly associated with high initial weight (r = 0.424, P = 0.049) and also high 
pre-treatment body weight (r = 0.678, P= 0.001). Treatment weight gain increased as the 
initial and pre-treatment weight gain increased in the control group. For the steers that 
were fed ZH, there was no significant correlation between the treatment body weight gain 
with initial weight (r = 0.097, P = 0.694) and also pre- treatment live weight (r = 0.393, P = 
0.096). Supplementation of ZH significantly increased (P < 0.0001) the dressing 
percentage (56.4% vs. 58.4%) and had no significant (P>0.05) effect on the carcass 
weight. The outcome of the study suggest that supplementation of ZH in the diet during 
the last month of the finishing period enhances growth performance and shows the 
repartitioning capacity of the feed additive as a beta- agonist. 
Keywords: Beta- adrenergic agonist, zilmax, growth performance, beef cattle, carcass 
characteristics 
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CHAPTER 1 
1. INTRODUCTION 
1.1 Background of study 
Market cattle become inefficient during the last month of the finishing period, because 
they start depositing less muscle and more fat (Radunz, 2011). The use of growth 
promoting agents such as beta adrenergic agents (βAA) has been studied since the 
1980s to improve growth performance, feed efficiency and final body weight (BW) during 
that period (Ricks et al., 1984b and c; Plascencia et al., 1999; Montgomery et al., 2009a 
and b). In addition to the improved cattle performance these βAA also increase the 
carcass weight, lean muscle and decrease fat deposition (Moloney et al., 1990; Chikhou 
et al., 1993a; Hilton et al., 2009).  
Zilpaterol hydrochloride (ZH) is a βAA that has been made commercially available in 
Mexico, South Africa and the United States of America (USA) as Zilmax (MSD) for use in 
feedlot cattle during the last 20 to 40 days. Dietary inclusion of ZH in cattle results in an 
increase in average daily gain (ADG), improved feed efficiency (G: F) (Montgomery et al., 
2009a; Avendano-Reyes et al., 2006) increased hot carcass weight, dressing percentage 
(Montgomery et al., 2009a, Chikhou et al.; 1993a; Fiems et al., 1993) and Longissimus 
muscle area (LM) (Plascencia et al., 1999). 
Meat tenderness is an important factor in eating experience by consumers when 
consuming beef (Miller et al., 2001). Supplementation of ZH to feedlot cattle has been 
shown to increase Warner-Bratzler shear force (WBSF). Feeding of ZH has been shown 
to decrease meat tenderness by sensory panel (Hilton et al., 2009) and to also negatively 
affect consumer sensory scores (Hilton et al., 2009; Leheska et al., 2009). Strydom et al. 
(1998) demonstrated a decrease of 19% in initial and 15% in sustained tenderness with a 
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45-d ZH treatment. Leheska et al. (2009) also demonstrated a difference of 11% in 
overall tenderness of control steaks over ZH. 
Hilton et al. (2009) and Leheska et al. (2009) demonstrated that supplementation of 
zilpaterol also decreased marbling score. However, in other studies marbling was not 
affected by zilpaterol treatment (Strydom et al., 1998, Plascencia et al.; 1999; Avendano- 
Reyes et al., 2006). 
 1.2 Problem statement 
Although previous research studies conducted have shown other AA such as cimaterol, 
clenbuterol, L644,969 and ractopamine to increase growth performance and several 
carcass characteristics (Ricks et al., 1984a; Moloney et al., 1990; Chikhou et al., 1993), 
there is still limited data on the effects of ZH and results are contradictory. Feeding of ZH 
has been recently linked to lameness and heat stress in feedlot cattle in the USA. These 
reports are contradictory to previous research studies where feeding of ZH has been 
shown not to affect morbidity in cattle fed in large commercial pens (Van Donkersgoed et 
al., 2011; Montgomery et al., 2009b). Therefore, more experiments need to be conducted 
on the effects of ZH feeding in order to determine potential reasons for the inconsistent 
response. 
1.3 Aims and objectives of the study 
The overall aim of the study is to evaluate the effects of feeding ZH to Bonsmara weaner 
steers. The specific objectives of the study will be to determine the effects of ZH on:  
a. Growth performance  
b. Carcass characteristics 
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CHAPTER 2 
2. LITERATURE REVIEW 
2.1 Growth promoters 
Growth promoters such as implants and beta- adrenergic agonists (βAA) are available for 
use in cattle to optimize production efficiency. These growth promoters primarily change 
partitioning of energy from feed and shuttle more to muscle instead of fat deposition, 
thereby increasing weight gain, ribeye area, and total red meat yield when used. Implants 
are products containing natural and synthetic hormones that are implanted in the ear and 
affect the hormone status of the animal to optimize growth (Radunz et al., 2011) whereas 
βAA are organic molecules that bind to adrenergic receptors and repartition nutrients to 
increase the lean/ adipose tissue ratio (Moody et al., 2000 and Ricks et al., 1984b) and 
do not affect the hormone status of the animal, thus are not steroids. 
2.1.1 Beta- adrenergic agonists 
Beta-adrenergic agonists (βAA) are naturally occurring or synthetic organic molecules 
which act upon the beta receptors. Synthetic βAA have the same chemical structure and 
pharmacological effect as the natural catecholamines dopamine, norepinephrine, and 
epinephrine (NRC, 1994; Bell et al., 1998) and can be subdivided into type 1 (β1AA) and 
type 2 (β2AA).  Adrenergic receptors are cell membrane receptors (Blair, 1983) and can 
be categorized into α and β receptors. - receptors are categorized into two types known 
as -1 and -2 receptors which are characterized by differing infinity for adrenalin and 
nor- adrenalin. 1 receptors have an affinity for two catecholamines and contract the 
heart muscle, whereas 2 receptors have an affinity for adrenalin and causes smooth 
muscle relaxation (Lands et al., 1967). The effects of βAA are pronounced in ruminants, 
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with stimulation of β-adrenergic receptors on cell surfaces causing substantially 
increased skeletal muscle mass, cross-sectional area of individual muscles, or both 
(Chung and Johnson, 2008). 
Strong type 2 beta adrenergic agonists (2AA) such as clenbuterol (Schiavetta et al., 
1990), L644, 969 (Moloney et al., 1990; Wheeler and Koohmaraie, 1992), and cimaterol 
(Quirke et al., 1988) have been shown to improve ADG and G:F and to also increase 
lean muscle and decrease fat deposition (Ricks et al., 1984b; Moloney et al., 1990; 
Chikhou et al., 1993b) as well as negatively affecting the beef shear force (Miller et al., 
1988; Boucque et al., 1994; Moloney et al., 1994) when fed to cattle. The undesirable 
effect of these AA on meat tenderness and shear force has been associated with an 
increase in preiger muscle calpastatin activity (Bardsley et al., 1992; Wheeler and 
Koohmaraie 1992; Luno et al., 1999). However, when the AA zilpaterol hydrochloride 
(ZH) is supplemented, the - calpain and calpastating activities are not affected (Hilton et 
al., 2009). 
Clenbuterol also decreases meat sensory panel scores for tenderness and juiciness 
(Luño et al., 1990). Geesink et al. (1993) demonstrated postmortem aging and muscle 
proteolysis to be significantly reduced in veal calves when clenbuterol is supplemented. 
Luño et al. (1999) and Wheeler and Koohmaraie (1992) also found similar results, where 
clenbuterol greatly reduced postmortem aging of muscles in heifers and steers as 
determined by sensory tenderness, WBSF and myofibril fragmentation index.  
Schroeder et al. (2003) demonstrated that the supplementation of 300 mg/ animal/ day of 
βAA ractopamine increased the beef shear force, decreased trained sensory panel initial 
and sustained tenderness scores whereas juiciness, beef flavor and off- flavor were not 
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affected by the treatment. However, he also demonstrated that decreased doses of 100 
and 200 mg/ animal/ day of ractopamine did not affect WBSF or sensory scores.  
In an experiment conducted by Van Donkersgoed et al. (2011) with heifers comparing 
effects of ZH and ractopamine treatments, cattle fed ZH had a reduced feed intake (0.3 
kg/ day) and had a heavier HCW (9.7 kg more). Other previous research studies have 
also demonstrated more carcass weight in steers fed ZH compared to ractopamine 
(Avendano- Reyes et al., 2006; Scramlin et al., 2010). It was also found that there were 
fewer Prime and AAA carcasses and more AA and A carcasses from heifers 
supplemented with ZH than from those fed ractopamine (Van Donkersgoed et al., 2011). 
The greater effectiveness of 2AA in comparison to ractopamine hydrochloride may have 
been due to the predominant distribution of - adrenergic receptor subtypes in bovine 
muscle and adipose tissue (Winterholler et al., 2007) 
2.1.2 Factors affecting effectiveness of beta- adrenergic agonists  
a. Age of animal 
When βAA are fed to younger cattle, they demonstrate little or no response in muscle 
deposition or efficiency thus resulting in not being cost effective to feed (Radunz, 2011). 
In most animals, the performance in response to βAA treatment is optimized with animal 
maturity. In a study when clenbuterol was supplemented, lambs with an initial weight of 
about 40kg gained more than the control but the βAA had no effect on the weight gain of 
the lambs with an initial weight of 37.5kg (Baker et al., 1984). Williams et al. (1986) also 
found that clenbuterol had no effect on the growth performance of veal calves. 
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b. Period of feeding Beta- adrenergic agonist 
Previous research trials have reported the use of ZH to be effective 20 to 40 days before 
slaughter. After this period the performance returns to the level prior to using the β-
agonist. The body adapts to the active ingredient during this time and thus loses its 
efficiency (Radunz, 2011). 
c. Dosage 
Research trials have reported that feeding - agonists at higher levels show little to no 
improvement on animal performance or muscle deposition and are not cost effective 
(Radunz, 2011). ZH has been approved for feeding to feedlot cattle at the rate of 7.5 to 
8.3 mg/kg of DM (FDA, 2006). 
d. Withdrawal period 
Approximately 4 to 8 days after AA are withdrawn from the diet, performance will return 
to the same level prior to the use of the feed additive. Hence, the animal will start to shift 
more energy to fat synthesis rather than muscle deposition. However, due to the rapid 
elimination (>95% in 72h), mainly via the urine (Shelver and Smith 2006), a withdrawal 
period of greater than 72h may result in the reversal of growth performance and carcass 
yield gains. Robles-Estrada et al., (2009) found that prolonging the period of ZH 
withdrawal pre-slaughter tended to decrease carcass adjusted ADG, G: F, apparent 
dietary net energy (NE), carcass dressing percentage and percentage lean yield. Beta-
adrenergic agonists having hydroxilated aromatic rings (like ZH) are metabolized by 
conjugation and have relatively short plasma half-lives (Sumano et al., 2002). 
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e. Pen size 
Greater responses have been observed in cattle fed in small research pens versus in 
large commercial feedlot pens. Montgomey et al. (2009a) reported a lower increase in 
ADG (14.2%) and feed efficiency (15.5%) when feedlot steers were fed zilpaterol in 
commercial large pens, whereas other researchers conducting experiments in smaller 
pens observed a higher increase. For example, Plascencia et al (1999) reported a 37% 
increase in ADG and a 39% increase in feed efficiency, respectively. 
f. Days on feedlot diet 
In a large pen in a commercial study with feedlot steers, ractopamine was shown to 
increase ADG (4.5%) and G: F (4.0%) over the entire 150 to 192-day feeding period, 
when it was fed during the final 28 days of feed but increasing days on feed from 150 to 
192 decreased ADG, G: F and DMI (Winterholler et al., 2007). 
g. Rate of absorption 
The effectiveness of ZH for promoting growth performance depends, in part, on the rate 
of absorption from the digestive tract and its half-life in tissues and body fluids (Murdoch 
et al., 2005). Other factors affecting efficiency include the degree of endogenous 
transformation and excretion rate (Smith, 1998). 
h. Sex of the animal 
In a study with poultry, Clenbuterol has been found to reduce abdominal fat and increase 
carcass protein in females only (Dalrymple et al., 1984a). In pigs clenbuterol reduced the 
rate of gain in barrows, but not in gilts (Ricks et al., 1984c). 
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i. Breed 
Research data on the effect of breed on the efficacy of βAA is still limited. The efficacy of 
clenbuterol has been demonstrated to be influenced by the strain in rats (Berne et al., 
1985). 
2.1.3. Negative consequences to feeding beta- adrenergic agonists 
Research has not observed any negative effects on animal conformation. However, cattle 
with poor skeletal structure (post legged, straight fronted), the added muscle could cause 
these problems to become more evident (Radunz, 2011) 
2.2 Zilpaterol hydrochloride 
Zilpaterol hydrochloride (ZH) is a type 2 beta-adrenergic agonists (2AA) that is 
commercially available and functions as a repartitioning agent similar to other βAA (Hilton 
et al., 2009). The repartitioning capacity of βAA like ZH (Hilton et al., 2009; Ricks et al., 
1984b), clenbuterol and ractopamine hydrochloride (Anderson et al., 1989) has been 
shown by a decrease in estimated carcass fat, increase in the estimated carcass protein 
and moisture. However, Ricks et al. (1984a) and Fiems et al. (1993) have observed that 
clenbuterol and cimaterol have much greater effect on decreasing estimated carcass fat 
than ZH (Hilton et al., 2009). 
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Figure 1.  Molecular structure of zilpaterol hydrochloride 
 
Source: Chemblink 
2.2.1 Effects of zilpaterol hydrochloride on: 
a. Performance of feedlot cattle 
Previous research conducted on feedlot steers has shown that zilpaterol hydrochloride 
(ZH) increases BW gain and G: F (Plascencia et al. 1999, Montgomery et al., 2009a and 
b; Casey et al., 1997b). In a study done by Montgomery et al. (2009b) to determine the 
effect of the feeding duration of ZH, dry matter intake (DMI) was significantly reduced by 
ZH supplementation in heifers. In the same study heifers and steers fed ZH for the 
duration of 40 days had greater DMI than the ones fed for the duration of 20 days but 
ADG and G: F were not affected. In contrast to that in a study done by Vasconcelos et al. 
(2008), ZH was found to decrease DMI as the duration of feeding the additive increased 
from 20 to 40 days and to also increase the FE. 
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In previous research studies where cattle were fed in small pens, no effects of feeding ZH 
(Montgomery et al., 2009b) or ractopamine (Schroeder et al., 2003; Gruber et al., 2007) 
on mortality were found. However, Montgomery et al. (2009a) observed that feeding of 
ZH increased mortality in steers fed in commercial large pens.  Feeding of ZH has been 
shown not to affect morbidity in cattle fed in large commercial pens (Van Donkersgoed et 
al., 2011; Montgomery et al., 2009b). 
b. Carcass characteristics 
Feeding of βAA has been reported to result in increased hot carcass weight (HCW) and 
dressing percentage (Chikhou et al., 1993a; Fiems et a., 1993; Avendano-Reyes., 2006; 
Montgomery 2009a). Previous research studies have demonstrated that feeding of ZH 
has been shown to increase dressing percentage, HCW and longissimus muscle (LM) 
area, whereas kidney, pelvic and heart fat (KPH) and marbling score were generally not 
affected (Casey et al., 1997a, b.; Plascencia et al., 1999; Robles-Estrada et al., 2009). 
ZH has also been shown to reduce yield grade (YG) and quality grade (QG) in feedlot 
heifers (Montgomery et al., 2009b; Robles- Estrada et al., 2009).  
Although previous trials have demonstrated no effects of ZH on the 12th- rib fat thickness 
(Casey et al., 1997a; Plascencia et al., 1999), Montgomery et al., (2009a) found a 9.5% 
decrease in the 12th- rib fat thickness when ZH was fed. He also demonstrated that the 
empty body fat was 3.3% less for steers fed ZH, resulting from decreased 12th-rib fat 
thickness and quality grade, and increased HCW and LM area. The author was of the 
opinion that ZH increases mature body size of steers fed βAA compared with the control 
at a common body composition (Owens et al., 1995; Guiroy et al., 2002) and is consistent 
with increased synthesis or decreased degradation of muscle protein (Beermann, 2002) 
and increased lipolysis, decreased fatty acid synthesis and esterification, or both 
(Mersmann, 2002). 
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Montgomery et al., (2009a) and Avendano-Reyes et al., (2006) also noted an increase in 
HCW that was greater than the increase in final BW when ZH was fed. This suggests a 
shift in mass from non-carcass to carcass tissues when βAA is fed. Several factors could 
have caused that, including decreased gut fill due to reduced feed intake, a greater 
repartitioning of fat and muscle in carcass than non-carcass tissues, or both 
(Montgomery et al., 2009a). 
c. Liver abscesses 
Research data regarding βAA effects on liver abscess is still limited. Although 
Montgomery et al., (2009a) found that supplementation of steers with ZH resulted in a 
decrease in liver abscess in spite of whether tylosin was fed in combination, Montgomery 
et al., (2009b) found that liver abscess rate was not affected when zilpaterol was fed. 
Montgomery et al., (2009a) suggested that the decrease in liver abscess when ZH was 
fed may be due to the decreased feed intake that occurs when ZH and other βAA are 
supplemented (Reeds and Mersmann, 1991; Bareille et al., 1997). 
d. Warner- Bratzler shear force (WBSF) values 
Supplementation of ZH has been shown to increase WBSF (Hilton et al., 2009; Leheska 
et al., 2009). Supplementation of ZH for 30 to 50 days has also been shown to increase 
WBSF of steaks from South African beef steers by 20 to 28% (Strydom et al., 2002) and 
to decrease with postmortem aging (Strydom and Nel, 1996). Hilton et al., (2009) 
reported that WBSF significantly decreased from 7 to 21 days postmortem among steaks 
from animals supplemented with ZH for 30 days. In contrast to other research studies, O’ 
Neill (2001) observed no differences in shear forces values for meat from control and 
treatment cattle and the author was of opinion that ZH did not reduce beef tenderness. 
12 
 
Strydom and Nel (1996) documented the effect of ZH supplementation on the shear force 
of several muscles, including triceps brachii. They found no difference between control 
and treated shear force values taken at 7 and 14 days postmortem. Brooks et al., (2009) 
reported a significant increase in WBSF of longissimus lumborum (LL), Triceps Brachii 
(TB) and Gluteus medius steaks (GM) steaks.  
e. Meat palatability 
Supplementation of ZH has also been shown to affect consumer sensory scores (Hilton 
et al., 2009; Leheska et al., 2009).  Hilton et al. (2009) reported a decrease in trained 
sensory panel juiciness, tenderness, beef flavour intensity and beef flavour by steaks 
from steers fed ZH compared to control. He also found that ZH treatment did not affect 
LM sensory panel off-flavour scores. The effects on juiciness, flavour intensity and beef 
flavour may have been attributed to decreased marbling (Montgomery et al., 2009 a and 
b). 
However in the same experiment, consumer overall acceptability, overall quality, beef 
flavour and juiciness were not affected by ZH treatment. Shackelford et al. (1991) 
demonstrated that LM WBSF limit was 4.6 kg for 88.6% consumer acceptance, whereas 
Miller et al. (2001) reported a LM WBSF threshold of 4.00 kg for 94% consumer 
satisfaction. The author concluded that ZH effects on shear force reduced with 
postmortem aging and tenderness of LM aged 14 days does not appear to adversely 
affect consumer acceptance of beef from ZH-treated cattle compared with cattle not fed 
ZH. 
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CHAPTER 3 
3. METHODOLOGY 
The study was conducted at the Agricultural Research Council - Animal Improvement 
Institute (ARC- API) Coordinates:  25º 53' 59.6" S 28º 12' 51.6" E, cattle feedlot and 
abattoir in Irene, Gauteng, South Africa. Animal ethical approval was obtained from the 
ARC – API and University of South Africa (UNISA) animal ethics committee. 
3.1 Animal management 
Forty one Bonsmara steers (age ±7 months, mean BW ±220 kg) were used for the 
experiment in 2012. For the first five days, the steers were maintained in holding pens 
with fresh water and fed hay ad libitum. The steers were subsequently processed on day 
five after arrival which included the following: weighing, vaccination against botulism and 
anthrax (Botuthrax, MSD), clostridial organisms (Covexin, Coopers), infectious bovine 
rhinotracheitis (IBR) and other respiratory diseases (Bovishield Gold 5, Pfizer), 
deworming (Lintex- 1, Bayer) and treated for external parasites, eartaged, implanted with 
Revalor S growth promoter (MSD). The steers were then placed in individual pens and 
weighed every two weeks throughout the four months trial. The steers were randomly 
allocated to the two treatments which consisted of ZH (22 steers) and control (without 
ZH) (19 steers). 
3.2 Diets and treatments 
During the first 18 days the steers were gradually adapted to a high concentrate diet 
(95%) using four transitional diets. Zilpaterol hydrochloride was included in one of the 
treatment diets for 28 consecutive days from day 89 and was withdrawn from the diet two 
days prior to slaughter of the animals. Feed bunks were evaluated visually in the morning 
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to determine the quantity of feed remaining from the previous day. Daily feed allotment to 
each pen was adjusted by < 5% to allow feed accumulation in the feed bunk. 
Contaminants in feed bunks were removed on a daily basis and orts were removed on a 
weekly basis. Feed refusal was measured and dry matter intake (DMI) was calculated. 
Feed ration samples were taken to the ARC- API commercial laboratory for nutrient 
analysis. The ingredient and nutrient composition of the final concentrate diet fed is 
shown in the following Table 1. 
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Table 1. Feed ingredients (%) and nutrient composition (g/kg DM, unless stated 
otherwise) of the finishing diet1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1
Finishing diet for the last 30 on feed, from start of zilpaterol hydrochloride (ZH) supplementation until 
slaughter  
2
Treatment without ZH in diet 
3
Treatment with ZH in diet 
4
aottonseed oil cake meal 
5
Zilpaterol Hydrochloride
 
6 
Metabolizable energy, estimated from gross energy (NRC, 1996) 
*Containing : 6×106 IU vit A; 3 g vit B1; 3.5 g; 30 g iron; 12 g Cu; 50 g,  Monensin included at 33mg/kg 
feed. 
 
 
Item Control
2 Zilpaterol3 
Ingredient,    
   Hominy chop 62 62 
   Wheat bran 15 15 
   Molasses meal 10 10 
   Cotton OCM4 5 5 
   Grass hay 4.5 4.5 
   Feedlime 1.6 1.6 
   Urea 1.3 1.3 
   Salt 0.5 0.5 
   *Premix 0.1 0.1 
Zilpaterol HCl5 mg/kg 0 8.3 
  
Nutrient composition (g/kg DM, unless states otherwise), 
Dry matter 873.3 873.3 
Crude protein 149.2 149.2 
Fat 63.4 63.4 
NDF 444.8 444.8 
Crude fibre 95.8 95.8 
ME (MJ/kg DM)6 11.41 11.41 
Starch 278.4 278.4 
Calcium 7.3 7.3 
Phosphorus 5.2 5.2 
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3.3 Health observations 
Animals were observed daily for signs of morbidity and other health conditions and 
recorded where applicable. 
3.4 Slaughter and carcass evaluation 
The cattle were slaughtered at the ARC abattoir. Hot carcass weights (HCW) were 
recorded on the day of slaughter. After the carcasses were chilled for 48 hours, the cold 
carcass weight (CCW) was measured. The dressing percentages were calculated as 
follows: (Hot Carcass Wt./Live Animal Wt.) X100. Fat scores were evaluated using the 
following scale: 0 = no fat, 6 = excessive fat. Dressing percentages were calculated.  
3.5 Statistical Analysis 
The data were analyzed using SPSS version 21. 2012. Pearson correlation coefficients 
between initial and pre-treatment weights with pre-treatment and treatment weight gains 
were computed. Independent samples t-tests were used to assess differences between 
means of the control steers and steers fed ZH on various growth performance indicators. 
Differences were regarded as significant at P <0.05. 
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CHAPTER 4 
4.1 RESULTS  
No incidences of mortality or morbidity were observed and special attention was made to 
observe for lameness, but no symptoms were observed. Means and standard errors for 
feedlot performance of the steers are presented in Table 2. 
Table 2. Means and SEM showing the effect of zilpaterol hydrochloride (ZH) on feedlot 
cattle performance  
Item Control ZH1 SEM P-value 
Number of steers 22 19   
Initial wt, kg 208.8 205.2 7.49 0.633 
Pre-treatment wt, kg 340.1 335.0 8.92 0.568 
Final wt, kg 375.4 381.2 12.03 0.632 
BW gain, pre-treatment, kg 131.3 129.8 6.90 0.826 
BW gain, treatment, kg 35.3b 46.2a 4.73 0.026* 
BW gain, day 1- end, kg 166.6 176.0 9.89 0.347 
ADG, pre-treatment, kg/d 1.39 1.35 0.09 0.655 
ADG, treatment, kg/d 1.10b 1.44a 0.15 0.026* 
ADG, day 1- end, kg/d 1.32 1.38 0.09 0.580 
DMI, pre-treatment, kg/d 6.568 6.471 0.30 0.747 
DMI, treatment, kg/d 7.862 8.100 0.41 0.568 
DMI, day 1- end, kg/d 6.876 6.853 0.31 0.942 
F:G, pre-treatment, kg/kg 4.869 4.849 0.24 0.933 
F:G, treatment, kg/kg 7.693 6.354 0.71 0.067 
F:G day 1- end, kg/kg 5.356 5.090 0.27 0.327 
*
Means differ significantly at P < 0.05. 
1
ZH- Zilpaterol hydrochloride 
BW- Body weight 
ADG- Average daily gain;  
DMI- Daily dry matter intake; 
F:G– feed to gain ratio, kg dry matter intake/ kg gain 
wt- weight 
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There were no significant differences (P > 0.05) on initial and pre-treatment body weights 
between the control and zilpaterol hydrochloride (ZH) group (Figure 2). Zilpaterol 
hydrochloride supplementation had no significant (P > 0.05) effect on the final body 
weights of the steers. 
 
 
Figure 2. Mean live body weight (BW) of the steers 
The mean total live BW gains are illustrated in Figure 3. No significant differences (P> 
0.05) on pre-treatment and overall BW gain were observed between the two groups. 
However, steers fed ZH had a significantly higher BW gain during the last 30 days of 
finishing period compared to the control steers (P = 0.026). Supplementation of ZH to the 
steers increased the BW gain by 10.9 kg (23.59%) during the last 30 days. 
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Figure 3. Mean live body weight (BW) gains of the steers 
Effect of initial weight on the last 30 days weight gain is shown in Figure 4. Effect of pre- 
treatment weight on the last 30 days weight gain is shown in Figure 5. Steers fed ZH 
gained more weight than the control during the treatment period. Pearson correlation 
analysis showed that there was significant positive correlation (r = 0.424, P = 0.049) 
between the initial weight and treatment weight gain and between the pre-treatment 
weight and treatment weight gain (r = 0.678, P = 0.001) during the last 30 days of the 
finishing period for the control group. High treatment weight gains are significantly 
associated with high initial weight and with high pre-treatment weights. Treatment weight 
gain increased as the initial and pre-treatment weight gain increased in the control group. 
For the ZH group, treatment weight gains were not significantly associated with initial 
weight (r = 0.097, P = 0.694) and pre- treatment body weight (r= 0.393, P = 0.096).  
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Figure 4. Effect of initial weight on treatment weight gain during the last 30 days. 
 
 
 
 
 
Figure 5. Effect of pre-treatment weight on treatment weight gain during the last 30 days. 
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The mean of average daily gains (ADG) of the steers during different periods of fattening 
are presented in Figure 6. Steers fed ZH had greater ADG during the last 30days of the 
trial compared to the control group (P < 0.05). As the treatment BW gain increased, the 
treatment ADG also improved. There were no significant differences (P > 0.05) observed 
on the daily dry matter intake (DMI) for the two treatments throughout the whole trial.  
 
 
Figure 6. Mean average daily gains (ADG) of the steers 
Feed efficiency (F: G) of the steers is presented in Figure 7. Pre- treatment feed 
conversion ratio was similar between the control and the steers fed ZH. ZH 
supplementation did not significantly influence the overall F:G but tended (P = 0.067) to 
increase the treatment F:G during the last month of the trial. 
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Figure 7. Mean feed efficiencies (F:G) of the steers  
The effect of ZH on carcass characteristics of the steers is presented in Table 3. 
Table 3.  Effect of zilpaterol hydrochloride (ZH) on carcass characteristics  
 of the steers 
Item Control ZH SEM P- value 
No. of carcasses 22 19   
Warm carcass wt. 211.8 222.7 7.01 0.129 
Cold carcass wt. 208.7 219.6 6.97 0.126 
Dressing percentage 56.4b 58.4 a 0.51 0.000* 
Fat score (%):     
+1 0 5.3   
-2 4.5 5.3   
 2 54.5 63.2   
+2 4.5 0   
-3 13.6 15.8   
 3 18.2 10.5   
+3 4.5 0   
     
ZH- Zilpaterol hydrochloride 
Fat score: 0-6 Scale; 0 = No fat, 6 = Excessive fat 
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 Supplementation of ZH to the steers had no significant effect (P > 0.05) on the hot and 
cold carcass weights (Figure 8). However, steers fed ZH had heavier carcasses 
compared to the control group by 10.9 kg.  
 
 
Figure 8. Effect of ZH on carcass weights of the steers  
The dressing percentage was significantly higher (P = 0.0000) for the steers fed ZH by 
2% (Figure 9).  
 
 
Figure 9. Mean of dressing percentages (Bars showing SE) 
24 
 
 
All the steers had a conformation of 3 and class of 1. Fat code classification of the 
carcasses is presented in Figure 10. Most steers had a carcass fat code of 2 (Lean). 
 
 
Figure 10. Fat code classification of the carcasses 
Fat scores: 0 = No fat, 6 = Excessive fat 
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CHAPTER 5 
5.1 DISCUSSION 
The results of the present study are similar to those observed by Holland et al. (2010), 
who also found that ZH supplementation had no effect on the final BW. The results of the 
present study also revealed that higher live body weight gains during the last 30 days of 
fattening were positively associated with higher initial and pre-treatment body weights 
(BW) in the control group. However, for the steers fed ZH, they was no association 
between the treatment weight gain with the initial weight and pre-treatment weight. This 
suggests that ZH supplementation during the last 30 days of fattening enhanced live 
body weight gain during that phase. 
In the present trial, ZH supplementation had a positive effect on the ADG of the steers 
during the last 30 days of fattening compared to the control group. Casey et al. (1997b) 
and Montgomery et al. (2009a) also reported an increase in ADG when ZH was 
supplemented to the diet. In previous trials conducted using other animals, an enhanced 
growth performance has been described as the effect of βAA when compared to controls. 
An increase in the rate of BW gain has been observed when cimaterol a βAA was fed to 
broilers (Dalrymple et al., 1984b), pigs (Walker et al., 1989) and also in lambs (Beermann 
et al., 1986). 
The effect of feeding ZH on DMI is inconsistent and varies among the previous research 
trials. The outcome of this study is similar to a study by Avendano-Reyes et al. (2006) 
who reported no significant differences in daily DMI when ZH was supplemented to the 
diet. However, the results are in contrast to those reported by Holland et al. (2010), who 
showed that ZH supplementation for 20 days decreased (P=0.02) DMI at the end of the 
finishing period. The improved feed efficiency has been described as the effect of ZH in 
previous studies (Plascencia et al., 1999; Beckett et al., 2009; McEvers et al., 2013). 
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Steers used in this trial exhibited lower feed efficiency than those observed in other ZH 
studies.  
The higher dressing percentages of steers fed ZH in the present study, is comparable to 
previous reports of the effects of ZH on dressing percentage (Avendano-Reyes et al., 
2006; Montgomery et al., 2009a; Chikhou et al., 1993; Fiems et al., 1993). In this study 
ZH tended to increase carcass weight. Montgomery et al. (2009b) reported that the HCW 
of steers fed ZH were 16.4 kg heavier and the dressing percentage also increased by 
1.5% compared to the control. The results of this study suggest the repartitioning 
capacity of ZH as a beta-adrenergic agonist. Feeding of βAA enhances muscling of the 
carcass and this was shown by an increase in the carcass weight. Most steers had a 
carcass fat score of 2 (lean) which is desirable for consumers in South Africa. 
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CHAPTER 6 
6.1 CONCLUSION AND RECOMMENDATIONS 
The outcome of the study demonstrated that ZH has the capacity to repartition tissue 
growth in steers to improve the carcass characteristics and yield. ZH significantly 
increased the rate of live BW gain during the last 30 days of fattening and also increased 
the muscle weight without causing any morbidity and mortality. ZH also did not cause any 
lameness in the cattle. The results of this study are similar to previous research trials, 
where ZH enhanced growth performance of the steers. More experiments with ZH need 
to be conducted in order to determine the factors affecting the efficacy of the βAA. 
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APPENDIX 
 
ANALYSIS OF ZILMAX DATA 
 
Group Statistics 
 Treatment 1 (N= 22) Treatment 2 (N= 19) 
Treatment Mean Std. Deviation Mean Std. Deviation 
Initial Weight 208.8 19.716 205.2 28.053 
Pre-Treatment Weight 340.1 29.790 335.0 26.870 
Final Weight 375.4 38.834 381.2 37.903 
Pre-Treatment Weight gain 131.3 24.849 129.8 18.204 
Treatment Weight Gain 35.3 11.869 46.2 18.177 
Final Weight gain 166.6 32.246 176.0 30.781 
Pre-Treatment Average Daily Gain 1.392 0.328 1.352 0.231 
Treatment Average Daily Gain 1.102 0.371 1.444 0.568 
Final Average Daily Gain 1.324 0.312 1.376 0.282 
Pre-Treatment Dry Matter Intake 6.568 1.006 6.471 0.882 
Treatment Dry Matter Intake 7.862 1.413 8.100 1.201 
Final Dry Matter Intake 6.876 1.070 6.853 0.856 
Pre Treatment Feed Conversion Ratio (F:G) 4.869 0.874 4.849 0.658 
Treatment Feed Conversion Ratio (F:G) 7.693 2.050 6.354 2.507 
Final Feed Conversion Ratio 5.356 0.941 5.090 0.744 
Warm Carcass Weight 211.8 22.003 222.7 22.828 
Cold Carcass Weight 208.7 21.781 219.6 22.778 
Dressing Percentage 56.4 1.524 58.4 1.710 
Table 1 Means and standard deviations for the various measurements 
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Carcass fat scores  
 
 
 
 
 
 
 
 
 
 
 
 
Fat Code Treatment 1 
N (%) 
Treatment 2 
N (%) 
+1 0 (0.0%) 1 (1 (5.3%) 
-2 1 (4.5%) 1 (5.3%) 
 2 12 (54.5%) 12 (63.2%) 
+2 1 (4.5%) 0 (0.0%) 
-3 3 (13.6%) 3 (15.8%) 
 3 4 (18.2%) 2 (10.5%) 
+3 1 (4.5%) 0 (0.0%) 
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 Levene's Test for Equality 
of Variances 
t-test for Equality of Means 
 F Sig. T df p-value 
 (2-tailed) 
Mean 
Difference 
Std. Error 
Difference 
Comments 
Initial Weight 2.135 .152 .481 39 .633 3.61 7.49 No significant difference 
Pre-Treatment Weight .257 .615 .576 39 .568 5.14 8.92 No significant difference 
Final Weight .221 .641 -.482 39 .632 -5.80 12.03 No significant difference 
Pre-Treatment Weight gain .463 .500 .222 39 .826 1.53 6.90 No significant difference 
Treatment Weight Gain 1.881 .178 -2.311 39 .026 -10.94 4.73 Significant difference 
Treatment 2 has a 
significantly higher 
treatment weight gain 
(mean = 46.2kg, std dev 
= 18.18) than Treatment  
1 (mean = 35.3kg, std 
dev = 11.87) Note that 
the coefficient of 
variation (cv) is 39.4% 
for Treatment 2 and 
33.6% for Treatment 1. 
Thus the trt weight 
gains for treatment 2 
are relatively more 
dispersed (or more 
variable) than the trt 
weight gains in 
Treatment 1. 
Final Weight gain .031 .861 -.951 39 .347 -9.41 9.89 No significant difference 
Pre-Treatment Average Daily Gain .976 .329 .450 39 .655 .04 .09 No significant difference 
Treatment Average Daily Gain 1.881 .178 -2.311 39 .026 -.34 .15 Significant difference 
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Treatment 2 (mean = 
1.44kg, std dev = 0.57) 
has a significantly ADG  
than Treatment  1 
(mean = 1.10kg, std dev 
= 0.37) Note that this 
information is simply a 
repetition of the results 
for Trt Weight Gain, 
since ADG is simply the 
trt weight gain divided 
by the nuber of days on 
treatment (in this case 
32 days). 
Final Average Daily Gain .074 .786 -.558 39 .580 -.05 .09 No significant difference 
Pre-Treatment Dry Matter Intake .022 .883 .326 39 .747 .10 .30 No significant difference 
Treatment Dry Matter Intake 1.042 .314 -.576 39 .568 -.24 .41 No significant difference 
Final Dry Matter Intake .473 .495 .073 39 .942 .02 .31 No significant difference 
Pre Treatment Feed Conversion Ratio (F:G) .132 .718 .084 39 .933 .02 .24 No significant difference 
Treatment Feed Conversion Ratio (F:G) .000 .993 1.882 39 .067 1.34 .71 No significant difference 
Final Feed Conversion Ratio .378 .542 .993 39 .327 .27 .27 No significant difference 
Warm Carcass Weight .003 .954 -1.552 39 .129 -10.88 7.01 No significant difference 
Cold Carcass Weight .000 1.000 -1.565 39 .126 -10.91 6.97 No significant difference 
Dressing Percentage .091 .765 -3.898 39 .000 -1.97 .51 Significant difference 
Treatment 2 has a 
significantly higher 
Dressing percentage 
(mean = 58.4%, std dev 
= 1.71) than Treatment  
1 (mean = 56.5%, std 
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dev = 1.52) Note that 
the coefficient of 
variation (cv) is 2.9% 
for Treatment 2 and 
2.7% for Treatment 1. 
Thus there is not much 
difference in the 
dispersion (or 
variability) in the 
dressing percentages 
observed in the two 
groups. 
Table 2: Independent Samples Tests for differences between the means of Treatment 1 and Treatment 2 
 
 
 
 
 
 
 
